Innovating Works

NSGENE

Desconocido
Training4CRM: European Training Network for Cell based Regenerative Medicine NSGENE AS participó en un H2020 H2020-MSCA-ITN-2016 The main objective of Training4CRM is to train a new generation of 15 highly inter-disciplinary early stage researchers at the highest inter...
2016-09-06 - 2020-10-31 | Financiado
PAIN-Net: Molecule to man pain network NSGENE AS participó en un H2020 H2020-MSCA-ITN-2016 Neuropathic pain affects 5% of the general population and 40% of patients with neurological diseases, and has a key role in the pathophysiol...
2016-08-31 - 2021-07-31 | Financiado
NeuEar: Neurotrophic Cochlear Implant for Severe Hearing Loss NSGENE AS tramitó un FP7 Sixteen percent of adult Europeans suffer from hearing loss, great enough to adversely affect their daily life. Over the age of 80, 50% of t...
Financiado
TREATPOLYQ: TreatPolyQ Industrial Academic Initial Training Network towards treatment of Polyglutamine Disease... NSGENE AS participó en un FP7 Protein aggregation is a hallmark of many late onset neurodegenerative disorders including Parkinson’s Disease (PD), Alzheimer’s Disease (AD...
Financiado
ARISE: Affording Recovery In Stroke NSGENE AS participó en un FP7 Stroke poses a massive clinical, social and economic burden, yet we have very limited effective therapies. This inadequacy is in spite of in...
Financiado
NEUROSTEMCELL: European Consortium for Stem Cell Therapy for Neurodegenerative Diseases NSGENE AS participó en un FP7 The NEuroStemCell consortium will foster collaboration between leading European experimental and clinical researchers in order to maximise t...
Financiado
EPIXCHANGE: Innovative gene therapies for epilepsy treatment NSGENE AS participó en un FP7 A significant part of the costs of neurological diseases on society is associated with epilepsy. About 30-40% of the patients are refractory...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.